Camille L Bedrosian insider trades

Open-market stock purchases and sales by Camille L Bedrosian, Chief Medical Officer at Amylyx Pharmaceuticals, Inc, from SEC Form 4 filings since Jan 30, 2018.

Recent trades

DateStockTradeValue
Sep 10, 2026AMLX Amylyx Pharmaceuticals, IncSold$256K
Sep 10, 2026AMLX Amylyx Pharmaceuticals, IncSold$68.9K
Sep 1, 2026CRNX Crinetics Pharmaceuticals, IncSold (not open market)$1.4M
Sep 1, 2026CRNX Crinetics Pharmaceuticals, IncSold (not open market)$504K
Sep 1, 2026CRNX Crinetics Pharmaceuticals, IncSold (not open market)$1.7M
Sep 1, 2026CRNX Crinetics Pharmaceuticals, IncSold (not open market)$1.1M
Sep 1, 2026CRNX Crinetics Pharmaceuticals, IncSold (not open market)$1.2M
Sep 1, 2026CRNX Crinetics Pharmaceuticals, IncSold (not open market)$1.1M
Sep 1, 2026CRNX Crinetics Pharmaceuticals, IncSold (not open market)$504K
Sep 1, 2026CRNX Crinetics Pharmaceuticals, IncSold (not open market)$545K
Sep 1, 2026CRNX Crinetics Pharmaceuticals, IncSold (not open market)$478K
Aug 18, 2026AMLX Amylyx Pharmaceuticals, IncBought (not open market)—
Jun 18, 2026CRNX Crinetics Pharmaceuticals, IncBought (not open market)—
Jun 18, 2026CRNX Crinetics Pharmaceuticals, IncBought (not open market)—
Mar 5, 2026AMLX Amylyx Pharmaceuticals, IncBought (not open market)—
Mar 5, 2026AMLX Amylyx Pharmaceuticals, IncBought (not open market)—
Mar 2, 2026AMLX Amylyx Pharmaceuticals, IncSold$94.2K
Dec 1, 2025AMLX Amylyx Pharmaceuticals, IncSold$94.4K

Companies traded

  • AMLX Amylyx Pharmaceuticals, Inc: 8 sales, last Sep 10, 2026
  • CRNX Crinetics Pharmaceuticals, Inc: other filings, last Sep 1, 2026
  • RYTM Rhythm Pharmaceuticals, Inc: other filings, last Jun 24, 2025
  • RARE Ultragenyx Pharmaceutical Inc: 12 sales, last Mar 1, 2023

Get free alerts when Camille L Bedrosian files a new trade →